{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:14:01Z","timestamp":1740172441307,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Von-Hippel-Lindau (VHL) is a genetic multisystem disorder characterized by visceral cysts and benign and malignant tumors in various organs. Herein, we present the case of a 23-year-old woman with VHL presenting with multiple gastric neuroendocrine neoplasms (gNENs) type 1 in the context of chronic autoimmune gastritis (CAG). Although gNENs are not acknowledged as a typical entity in VHL patients, in the present case, gNENs were composed of neoplastic cells with clear cytoplasm usually seen in tumors related to VHL disease. We additionally performed a literature review on the presence of neuroendocrine clear cell tumors and report on further cases of clear cell NENs. The present case illustrates that clear-cell transformation in gNENs may be due to the dual genetic background of the patient; the real oncogenic stimulus may be more closely related to CAG than to VHL disease accompanied by an interplay between neoplastic and autoimmune processes. Therefore, close monitoring of patients with clear cell NENs appears to be important before excluding VHL disease, even in the context of phenotypically unrelated diseases.<\/jats:p>","DOI":"10.1007\/s42000-024-00556-9","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:02:25Z","timestamp":1713160945000},"page":"585-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When rare diseases crisscross within the same patient: von Hippel-Lindau and type 1 gastric neuroendocrine tumor"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-6768","authenticated-orcid":false,"given":"Krystallenia I.","family":"Alexandraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadni","family":"Spyroglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Xekouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos I.","family":"Bramis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis S.","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manousos","family":"Konstadoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"556_CR1","unstructured":"Binderup MLM (2018) von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome. Dan Med J 65:B5461"},{"key":"556_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"ML Binderup","year":"2022","unstructured":"Binderup ML, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG et al (2022) von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. Eur J Med Genet 65:104538","journal-title":"Eur J Med Genet"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.febslet.2012.04.032","volume":"586","author":"HL Bader","year":"2012","unstructured":"Bader HL, Hsu T (2012) Systemic VHL gene functions and the VHL disease. FEBS Lett 586:1562\u20131569","journal-title":"FEBS Lett"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S et al (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3:1335\u20131342","journal-title":"JAMA Oncol"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ecl.2018.04.013","volume":"47","author":"S Grozinsky-Glasberg","year":"2018","unstructured":"Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S et al (2018) Gastric Carcinoids. Endocrinol Metab Clin North Am 47:645\u2013660","journal-title":"Endocrinol Metab Clin North Am"},{"key":"556_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/cen.12476","volume":"81","author":"G Kaltsas","year":"2014","unstructured":"Kaltsas G, Grozinsky-Glasberg S, Alexandraki KI, Thomas D, Tsolakis AV et al (2014) Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) 81:157\u2013168","journal-title":"Clin Endocrinol (Oxf)"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/cen.12346","volume":"80","author":"KI Alexandraki","year":"2014","unstructured":"Alexandraki KI, Nikolaou A, Thomas D, Syriou V, Korkolopoulou P et al (2014) Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1? Clin Endocrinol (Oxf) 80:685\u2013690","journal-title":"Clin Endocrinol (Oxf)"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/cen.14055","volume":"91","author":"K Daskalakis","year":"2019","unstructured":"Daskalakis K, Tsoli M, Karapanagioti A, Chrysochoou M, Thomas D et al (2019) Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) 91:534\u2013543","journal-title":"Clin Endocrinol (Oxf)"},{"key":"556_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13306","volume":"35","author":"F Panzuto","year":"2023","unstructured":"Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J et al (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1\u2013G3. J Neuroendocrinol 35:e13306","journal-title":"J Neuroendocrinol"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/2050640619890465","volume":"8","author":"RE Rossi","year":"2020","unstructured":"Rossi RE, Invernizzi P, Mazzaferro V, Massironi S (2020) Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis. United European Gastroenterol J 8:140\u2013147","journal-title":"United European Gastroenterol J"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2169\/internalmedicine.8701-21","volume":"61","author":"K Kawaguchi","year":"2022","unstructured":"Kawaguchi K, Yashima K, Ikebuchi Y, Yoshida A, Kuwamoto S et al (2022) The First Case of Gastric Neuroendocrine Tumors Induced by a Proton Pump Inhibitor in von Hippel-Lindau Disease. Intern Med 61:2587\u20132592","journal-title":"Intern Med"},{"key":"556_CR12","first-page":"83","volume":"38","author":"CG Woo","year":"2017","unstructured":"Woo CG, Choi SY, Kwak JJ, Chin S, Kim HK (2017) Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review. Neuro Endocrinol Lett 38:83\u201386","journal-title":"Neuro Endocrinol Lett"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00000478-200105000-00006","volume":"25","author":"MP Hoang","year":"2001","unstructured":"Hoang MP, Hruban RH, Albores-Saavedra J (2001) Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease. Am J Surg Pathol 25:602\u2013609","journal-title":"Am J Surg Pathol"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/00000478-200110000-00017","volume":"25","author":"PA Sinkre","year":"2001","unstructured":"Sinkre PA, Murakata L, Rabin L, Hoang MP, Albores-Saavedra J (2001) Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease. Am J Surg Pathol 25:1334\u20131339","journal-title":"Am J Surg Pathol"},{"key":"556_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","volume":"463","author":"H Gucer","year":"2013","unstructured":"Gucer H, Szentgyorgyi E, Ezzat S, Asa SL, Mete O (2013) Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. Virchows Arch 463:593\u2013597","journal-title":"Virchows Arch"},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.2174\/138161209789649394","volume":"15","author":"VH Haase","year":"2009","unstructured":"Haase VH (2009) The VHL tumor suppressor: master regulator of HIF. Curr Pharm Des 15:3895\u20133903","journal-title":"Curr Pharm Des"},{"key":"556_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.821598","volume":"13","author":"Z Elkoshi","year":"2022","unstructured":"Elkoshi Z (2022) Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites? Front Immunol 13:821598","journal-title":"Front Immunol"},{"key":"556_CR18","doi-asserted-by":"publisher","unstructured":"Norata D, Peri M, Giammalva GR, Lupica A, Paolini F, et al (2023) Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis. Diagnostics (Basel) 13. https:\/\/doi.org\/10.3390\/diagnostics13010144","DOI":"10.3390\/diagnostics13010144"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:19:11Z","timestamp":1727421551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00556-9","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from the individual included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}